SEC Form 4 · accession 0001209191-16-113903
Horizon Pharma plc · HZNP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Geoffrey M. Curtis
Officer — SVP, Corporate Communications
Period of report
Apr 8, 2016
Accepted (ET)
Apr 11, 2016 · 6:20 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001492426
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1 | Apr 8, 2016 | M | 7,000 | — | A | 7,258 | D | |
| Ordinary Shares | Apr 8, 2016 | F | 2,177 | $18.80 | D | 5,081 | D | |
| Ordinary Shares | holding | — | — | — | 420 | I | By Spouse |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F2 | — | Apr 8, 2016 | M | 7,000 | D | — | — | Ordinary Shares | 7,000 | 21,000 | D |
Explanation of responses
- F1Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer.
- F2On April 8, 2015 and May 1, 2015, the reporting person was granted an aggregate of 28,000 restricted stock units. The restricted stock units vest in four equal annual installments beginning on April 8, 2016.